Mette Hazenberg | EHA 2018 | FMT as therapy for steroid-refractory GvHD

Anna Bartus

James Badman

Mette Hazenberg

Jun 20, 2018

Mette Hazenberg discusses FMT as therapy for steroid-refractory GvHD at EHA 2018

Mette Hazenberg | EHA 2018 | FMT as therapy for steroid-refractory GvHD

More about...

Acute graft-versus-host disease Anna Bartus EHA 2018 Fecal microbiota transplant James Badman Mette Hazenberg Steroid-refractory GvHD

FDA grants ALPN-101 an Orphan Drug Designation for the prevention and treatment of acute GvHD

On March 18, 2020, the U.S. Food and Drug Administration (FDA) granted an Orphan Drug Designation for ALPN-101 for the prevention and treatment of acute...

Apr 6, 2020

FDA grants ALPN-101 an Orphan Drug Designation for the prevention and treatment of acute GvHD

On March 18, 2020, the U.S. Food and Drug Administration (FDA) granted an Orphan Drug Designation for...

Apr 6, 2020

Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract

Results from a retrospective study in Annals of Hematology demonstrated that ileostomy induced significant clinical responses in patients with...

Aug 28, 2019

Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract

Results from a retrospective study in Annals of Hematology demonstrated that ileostomy induced significant...

Aug 28, 2019

Subscribe to get the best content related to GvHD delivered to your inbox every month

First Name

Last Name

I agree to the GvHD Hub Terms & Conditions

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Mette Hazenberg | EHA 2018 | FMT as therapy for steroid-refractory GvHD

Anna Bartus

James Badman

Mette Hazenberg

Jun 20, 2018

More about...

Related articles

Apr 6, 2020

Apr 6, 2020

Aug 28, 2019

Aug 28, 2019

Newsletter